NeuBase Therapeutics Inc

NASDAQ:NBSE   3:09:35 PM EDT
4.96
-0.31 (-5.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

NeuBase Therapeutics Inc Stock, NASDAQ:NBSE

700 Technology Drive, Third floor, Pittsburgh, Pennsylvania 15219
United States of America
Phone: +1.646.45.1790
Number of Employees: 15

Description

NeuBase Therapeutics, Inc. is a biotechnology company. It engages in the development of drugs for patients with genetic neurological disorder. The firms pipelines include Huntingtonâ??s Disease, NT0100 Program - PATrOL Enabled gamma-PNA for Huntington's Disease, and NT0200 Program- PATrOL Enabled gamma-PNA for Myotonic Dystophy. The company was founded by Dietrich A. Stephan on August 28, 2018 and is headquartered in Pittsburgh, PA.